Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Treace Medical Concepts (TMCI) Research & Development (2020 - 2025)

Historic Research & Development for Treace Medical Concepts (TMCI) over the last 6 years, with Q3 2025 value amounting to $4.7 million.

  • Treace Medical Concepts' Research & Development fell 570.22% to $4.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.0 million, marking a year-over-year increase of 726.54%. This contributed to the annual value of $20.6 million for FY2024, which is 3334.84% up from last year.
  • Per Treace Medical Concepts' latest filing, its Research & Development stood at $4.7 million for Q3 2025, which was down 570.22% from $5.5 million recorded in Q2 2025.
  • Over the past 5 years, Treace Medical Concepts' Research & Development peaked at $5.6 million during Q1 2025, and registered a low of $1.9 million during Q1 2021.
  • In the last 5 years, Treace Medical Concepts' Research & Development had a median value of $3.8 million in 2022 and averaged $4.0 million.
  • Per our database at Business Quant, Treace Medical Concepts' Research & Development skyrocketed by 14663.95% in 2021 and then crashed by 570.22% in 2025.
  • Over the past 5 years, Treace Medical Concepts' Research & Development (Quarter) stood at $3.4 million in 2021, then grew by 11.02% to $3.7 million in 2022, then increased by 10.75% to $4.2 million in 2023, then grew by 25.48% to $5.2 million in 2024, then dropped by 10.17% to $4.7 million in 2025.
  • Its last three reported values are $4.7 million in Q3 2025, $5.5 million for Q2 2025, and $5.6 million during Q1 2025.